These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 30173781)

  • 41. Intraoperative prognostic factors and atypical patterns of recurrence in patients with upper urinary tract urothelial carcinoma treated with laparoscopic radical nephroureterectomy.
    Carrion A; Huguet J; García-Cruz E; Izquierdo L; Mateu L; Musquera M; Ribal MJ; Alcaraz A
    Scand J Urol; 2016 Aug; 50(4):305-12. PubMed ID: 26926709
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fluorodeoxyglucose positron emission tomography/computed tomography for diagnosis of upper urinary tract urothelial carcinoma.
    Asai S; Fukumoto T; Tanji N; Miura N; Miyagawa M; Nishimura K; Yanagihara Y; Shirato A; Miyauchi Y; Kikugawa T; Yokoyama M
    Int J Clin Oncol; 2015 Oct; 20(5):1042-7. PubMed ID: 25794920
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ureteroscopic and percutaneous management of upper tract urothelial carcinoma (UTUC): systematic review.
    Cutress ML; Stewart GD; Zakikhani P; Phipps S; Thomas BG; Tolley DA
    BJU Int; 2012 Sep; 110(5):614-28. PubMed ID: 22471401
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Location of the primary tumor is not an independent predictor of cancer specific mortality in patients with upper urinary tract urothelial carcinoma.
    Isbarn H; Jeldres C; Shariat SF; Liberman D; Sun M; Lughezzani G; Widmer H; Arjane P; Pharand D; Fisch M; Graefen M; Montorsi F; Perrotte P; Karakiewicz PI
    J Urol; 2009 Nov; 182(5):2177-81. PubMed ID: 19758662
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ureteroscopic and extirpative treatment of upper urinary tract urothelial carcinoma: a 15-year comprehensive review of 160 consecutive patients.
    Grasso M; Fishman AI; Cohen J; Alexander B
    BJU Int; 2012 Dec; 110(11):1618-26. PubMed ID: 22458598
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prospective analysis of Ki-67 as an independent predictor of oncologic outcomes in patients with high grade upper tract urothelial carcinoma.
    Krabbe LM; Bagrodia A; Lotan Y; Gayed BA; Darwish OM; Youssef RF; John G; Harrow B; Jacobs C; Gaitonde M; Sagalowsky AI; Shariat SF; Kapur P; Margulis V
    J Urol; 2014 Jan; 191(1):28-34. PubMed ID: 23871758
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Stage-specific impact of tumor location on oncologic outcomes in patients with upper and lower tract urothelial carcinoma following radical surgery.
    Rink M; Ehdaie B; Cha EK; Green DA; Karakiewicz PI; Babjuk M; Margulis V; Raman JD; Svatek RS; Fajkovic H; Lee RK; Novara G; Hansen J; Daneshmand S; Lotan Y; Kassouf W; Fritsche HM; Pycha A; Fisch M; Scherr DS; Shariat SF; ;
    Eur Urol; 2012 Oct; 62(4):677-84. PubMed ID: 22349570
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Degree of hydronephrosis predicts adverse pathological features and worse oncologic outcomes in patients with high-grade urothelial carcinoma of the upper urinary tract.
    Chung PH; Krabbe LM; Darwish OM; Westerman ME; Bagrodia A; Gayed BA; Haddad AQ; Kapur P; Sagalowsky AI; Lotan Y; Margulis V
    Urol Oncol; 2014 Oct; 32(7):981-8. PubMed ID: 25022858
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neoplasms of the upper urinary tract: a review with focus on urothelial carcinoma of the pelvicalyceal system and aspects related to its diagnosis and reporting.
    Gupta R; Paner GP; Amin MB
    Adv Anat Pathol; 2008 May; 15(3):127-39. PubMed ID: 18434765
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Contralateral upper tract urothelial carcinoma after nephroureterectomy: the predictive role of DNA methylation.
    Zhang L; Xiong G; Fang D; Li X; Liu J; Ci W; Zhao W; Singla N; He Z; Zhou L
    J Exp Clin Cancer Res; 2015 Jan; 34(1):5. PubMed ID: 25613404
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Laparoscopic radical nephroureterectomy is associated with worse survival outcomes than open radical nephroureterectomy in patients with locally advanced upper tract urothelial carcinoma.
    Kim HS; Ku JH; Jeong CW; Kwak C; Kim HH
    World J Urol; 2016 Jun; 34(6):859-69. PubMed ID: 26497823
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Upper urinary tract tumor and hydronephrosis to pelviureteric junction obstruction: a rare association].
    Ennaciri S; Omana JP
    Pan Afr Med J; 2018; 31():201. PubMed ID: 31447962
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evidence-based sex-related outcomes after radical nephroureterectomy for upper tract urothelial carcinoma: results of large multicenter study.
    Fernández MI; Shariat SF; Margulis V; Bolenz C; Montorsi F; Suardi N; Remzi M; Wood CG; Roscigno M; Kikuchi E; Oya M; Zigeuner R; Langner C; Weizer A; Lotan Y; Koppie TM; Raman JD; Karakiewicz P; Bensalah K; Schultz M; Bernier P
    Urology; 2009 Jan; 73(1):142-6. PubMed ID: 18845322
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Predictive and Prognostic Value of Preoperative Thrombocytosis in Upper Tract Urothelial Carcinoma.
    Foerster B; Moschini M; Abufaraj M; Soria F; Gust KM; Rouprêt M; Karakiewicz PI; Briganti A; Rink M; Kluth L; Mathieu R; Margulis V; Lotan Y; Aziz A; John H; Shariat SF;
    Clin Genitourin Cancer; 2017 Dec; 15(6):e1039-e1045. PubMed ID: 28694147
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Predictive Value of Flank Pain and Gross Hematuria on Long-Term Survival in Patients With Upper Tract Urothelial Carcinoma Treated by Radical Nephroureterectomy.
    Sun KN; Wu JH; Chen ZH; He YJ; Chen YL; Hu JZ; Sheng L
    Clin Med Insights Oncol; 2023; 17():11795549221147993. PubMed ID: 36685988
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparative analysis of comorbidity and performance indices for prediction of oncological outcomes in patients with upper tract urothelial carcinoma who were treated with radical nephroureterectomy.
    Aziz A; Fritsche HM; Gakis G; Kluth LA; Hassan Fa; Engel O; Dahlem R; Otto W; Gierth M; Denzinger S; Schwentner C; Stenzl A; Shariat SF; Fisch M; Burger M; Rink M
    Urol Oncol; 2014 Nov; 32(8):1141-50. PubMed ID: 24856977
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [A clinical survey of 7 cases with primary ureteral tumor: experiences in a year].
    Takeda M; Takeda M; Takahashi H; Go H
    Hinyokika Kiyo; 1985 Sep; 31(9):1553-7. PubMed ID: 4083213
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The prognostic predictors of primary ureteral transitional cell carcinoma after radical nephroureterectomy.
    Li WM; Li CC; Ke HL; Wu WJ; Huang CN; Huang CH
    J Urol; 2009 Aug; 182(2):451-8; discussion 458. PubMed ID: 19524962
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Factors affecting the survival of patients treated by standard nephroureterectomy for transitional cell carcinoma of the upper urinary tract.
    Ataus S; Onal B; Tunc B; Erozenci A; Cekmen A; Kural AR; Oner A
    Int Urol Nephrol; 2006; 38(1):9-13. PubMed ID: 16502046
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact of tumour size on prognosis of upper urinary tract urothelial carcinoma after radical nephroureterectomy: a multi-institutional analysis of 795 cases.
    Shibing Y; Liangren L; Qiang W; Hong L; Turun S; Junhao L; Lu Y; Zhengyong Y; Yonghao J; Guangqing F; Yunxiang L; Dehong C
    BJU Int; 2016 Dec; 118(6):902-910. PubMed ID: 26935344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.